Literature DB >> 23327291

Quantitative polymerase chain reaction detection of CEP110-FGFR1 fusion gene in a patient with 8p11 myeloproliferative syndrome.

Shohei Yamamoto, Yasuhiro Ebihara, Shinji Mochizuki, Toshiro Kawakita, Seiko Kato, Jun Ooi, Satoshi Takahashi, Arinobu Tojo, Nozomi Yusa, Yoichi Furukawa, Naoki Oyaizu, Junichi Watanabe, Ken Sato, Fumihiko Kimura, Kohichiro Tsuji.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23327291     DOI： 10.3109/10428194.2013.767455

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

1.  Reply to the letter by Yang et al. RE: acute myeloid leukemia associated with FGFR1 abnormalities.

Authors:  Yonggoo Kim; Hyeyoung Lee; Myungshin Kim
Journal:  Int J Hematol       Date:  2013-06-05       Impact factor: 2.490

2.  Dysregulated signaling pathways in the development of CNTRL-FGFR1-induced myeloid and lymphoid malignancies associated with FGFR1 in human and mouse models.

Authors:  Mingqiang Ren; Haiyan Qin; Eiko Kitamura; John K Cowell
Journal:  Blood       Date:  2013-06-18       Impact factor: 22.113

3.  Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1.

Authors:  Shohei Yamamoto; Makoto Otsu; Emiko Matsuzaka; Chieko Konishi; Haruna Takagi; Sachiyo Hanada; Shinji Mochizuki; Hiromitsu Nakauchi; Kohzoh Imai; Kohichiro Tsuji; Yasuhiro Ebihara
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.